Diamond Biofund Inc. 6901.TW TAI · Financials · Taiwan
$14.20 +3.27% +$0.45
Summary
74 / 100 · Bulios Score
What speaks for it
- Out of every 100 TWD of revenue, 93 TWD is left as net profit.
- The share price is below the Bulios Fair Price.
What to watch
- It missed profit estimates 4 times in the last 7 quarters.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapBy our assumptions the business is worth more than its shares cost today.
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 4.0 TWD for 1 TWD of yearly profit.
Valuation in detailIs it growing?
It is shrinkingRevenue (TWD)
Diluted EPS (TWD)
There is not enough revenue history yet to say how fast it grows.
Growth in detailDoes it make money?
Very wellWhere 100 TWD of revenue goes
- Cost of sales 1.5 TWD
- Sales and administration 23 TWD
- Taxes and other -1.5 TWD
- Net profit 78 TWD
Net profit, industry median (Asset Management) 34 TWD
Out of every 100 TWD of revenue, 78 TWD is left as net profit.
Profitability in detailIs it financially healthy?
Banks and insurers work with their customers' money, so their debt is judged differently; see the health section for their capital figures.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
No coverageNo analyst covers this stock.
Analysts in detail